AstraZeneca´s Seroquel, Seroquel XR Gets Approval In Europe For Bipolar DisorderAstraZeneca Plc schizophrenia drug Seroquel, won European approval for wider use of both the original and the new version (XR) of its blockbuster antipsychotic in treating major depressive episodes in bipolar disorder. Seroquel XR has also been cleared for the treatment of moderate to severe manic episodes in bipolar disorder.
11-13-2008 |
09:23 hs.
|
Anglo-Swedish drug firm AstraZeneca Plc announced that its anti-psychotic drugs Seroquel and Seroquel XR have been approved in Europe for the treatment of major depressive episodes in bipolar disorder. Seroquel XR has also been cleared for the treatment of moderate to severe manic episodes in bipolar disorder in Europe. Seroquel XR was approved to control depressive and manic symptoms of bipolar disorder in the U.S. last month. First nine month sales of the drug were $3.3 billion. Publish comment:
|
Estimated reading time: 0:43
Word count: 961
![]() Most read articles ASCO Congress: Roche Present Phase II Data For Trastuzumab-DM1 // 05/29/2009 Nexavar: Bayer and Onyx Initiate Phase III Trial For Non-Small Cell Lung Cancer Drug. // 06/02/2009
2008, Will be the Year of...
|



